Related Experiment Video
Updated: Jun 6, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Obesity and arterial hypertension]
L Gaspar1, P Poliak, M Makovník
1II. Interná klinika lekárskej fakulty UKa FNsP Bratislava, Slovenská republika. ludovitgaspar@yahoo.com
Vnitrni Lekarstvi
|November 26, 2010
Summary
Obesity is a key risk factor for hypertension, cardiovascular disease, and chronic kidney disease. Addressing obesity, especially visceral fat, may prevent related cardiovascular and kidney complications.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Syndrome
Background:
- Obesity is a significant independent risk factor for hypertension, cardiovascular disease, and chronic kidney disease.
- Emerging evidence suggests obesity and metabolic abnormalities contribute to renal complications in essential hypertension.
- The metabolic syndrome, characterized by obesity, has implications for preventing cardiovascular and renal morbidity.
Purpose of the Study:
- To explore the link between obesity, metabolic syndrome, and renal complications in essential hypertension.
- To investigate the potential benefits of targeting visceral obesity for cardiovascular and renal health.
Main Methods:
- Review of existing literature on obesity, metabolic syndrome, and hypertension.
- Analysis of epidemiological data linking obesity to cardiovascular and renal diseases.
- Exploration of mechanistic pathways through which obesity affects kidney function.
Main Results:
- Obesity independently increases the risk of developing and worsening hypertension, cardiovascular disease, and chronic kidney disease.
- Metabolic abnormalities associated with obesity accelerate renal complications in essential hypertension.
- Interventions targeting visceral obesity may offer protective effects against cardiovascular and renal morbidity.
Conclusions:
- Obesity is a critical modifiable risk factor for cardiovascular and renal diseases.
- Managing obesity and metabolic syndrome is crucial for preventing hypertension-related complications.
- Targeting visceral obesity presents a promising strategy for improving cardiovascular and renal outcomes.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...